SCOPE - Scandinavian studies of COVID-19 in Pregnancy

Grant number: 105545

Grant search

Key facts

  • Disease

    COVID-19
  • start year

    -99
  • Known Financial Commitments (USD)

    $0
  • Funder

    NordForsk
  • Principal Investigator

    Siri Håberg
  • Research Location

    Sweden
  • Lead Research Institution

    Norwegian Institute of Public Health
  • Research Priority Alignment

    N/A
  • Research Category

    Clinical characterisation and management

  • Research Subcategory

    Prognostic factors for disease severity

  • Special Interest Tags

    N/A

  • Study Type

    Unspecified

  • Clinical Trial Details

    N/A

  • Broad Policy Alignment

    Pending

  • Age Group

    Adults (18 and older)

  • Vulnerable Population

    Pregnant women

  • Occupations of Interest

    Unspecified

Abstract

It is not known is pregnant women are especially susceptible to COVID-19, or if they are at higher risk of developing severe symptoms and complications. Many countries have included pregnant women in the group of particularly susceptible individuals, out of a precautionary principle. The limited evidence available today, do suggest that pregnant women with COVID-19 and their newborns are at increased risk of adverse outcomes, and vertical transmission (from mother to foetus) cannot be ruled out and may affect foetuses in as yet unrecognized ways. Our multidisciplinary Scandinavian team has expertise in perinatal epidemiology, in social epidemiology, in surveillance, and in obstetrics. We have extensive experience in using national registries to study pregnancy outcomes after infections and pandemics. Our main objective is to fill three crucial knowledge gaps: Are pregnant women more likely to contract COVID-19, and at a higher risk of severe disease, complications and hospitalizations than non-pregnant women of reproductive age? If so, which underlying characteristics, e.g. housing and working conditions, affect the risk of severe COVID-19 in pregnant women? Does COVID-19 in pregnancy increase the risk of pregnancy complications, including fetal loss? Does maternal COVID-19 during pregnancy adversely affect the health of the child? To address these questions, we will use unique register data on health and social factors on all women in the reproductive age, together with clinical data on the COVID-19 infections. Combining results from the three Scandinavian countries will strengthen our ability to study severe COVID-19 illness, susceptible subgroups and non-frequent outcomes. The Scandinavian countries have had different course of the pandemic, and this enables us to compare results from different contexts with similar data resources. If findings differ between countries, it may point to social structures or other causes than COVID-19 for adverse pregnancy outcomes.

Publicationslinked via Europe PMC

Last Updated:an hour ago

View all publications at Europe PMC

Temporal trends and determinants of COVID-19 vaccine series initiation after recent pregnancy.

Association between SARS-CoV-2 infection and newly diagnosed hypertension during pregnancy: prospective, population based cohort study.

Severe COVID-19 during pregnancy in Sweden, Norway, and Denmark.

Temporal trends and determinants of COVID-19 vaccine coverage and series initiation during pregnancy in Ontario, Canada, December 2020 to December 2021: A population-based retrospective cohort study.

Changes in preterm birth and stillbirth during COVID-19 lockdowns in 26 countries.

Adverse maternal, fetal, and newborn outcomes among pregnant women with SARS-CoV-2 infection: an individual participant data meta-analysis.

Pregnancy Status at the Time of Coronavirus Disease 2019 Vaccination and Incidence of Severe Acute Respiratory Syndrome Coronavirus 2 Infection.

Fetal death after the introduction of COVID-19 mitigation measures in Sweden, Denmark and Norway: a registry-based study.

Impact of COVID-19 on pregnancy-related healthcare utilisation: a prospective nationwide registry study.